| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.093 | 0.006 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.006 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.007 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.007 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.007 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.008 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.086 | 0.009 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.01 |